1. Puthucheary Z, Skipworth JR, Rawal J, Loosemore M, Van Someren K, Montgomery HE. Genetic influences in sport and physical performance. Sports medicine. 2011;41(10):845-59.
2. Ma F, Yang Y, Li X, Zhou F, Gao C, Li M, et al. The association of sport performance with ACE and ACTN3 genetic polymorphisms: a systematic review and meta-analysis. PloS one. 2013;8(1):e54685.
3. Tanisawa K, Wang G, Seto J, Verdouka I, Twycross-Lewis R, Karanikolou A, et al. Sport and exercise genomics: the FIMS 2019 consensus statement update. British journal of sports medicine. 2020;54(16):969-75.
4. Maciejewska-Skrendo A, Cięszczyk P, Chycki J, Sawczuk M, Smółka W. Genetic markers associated with power athlete status. Journal of human kinetics. 2019;68(1):17-36.
5. Gineviciene V, Jakaitiene A, Aksenov M, Aksenova A, Astratenkova ADI, Egorova E, et al. Association analysis of ACE, ACTN3 and PPARGC1A gene polymorphisms in two cohorts of European strength and power athletes. Biology of sport. 2016;33(3):199.
6. Zarebska A, Sawczyn S, Kaczmarczyk M, Ficek K, Maciejewska-Karlowska A, Sawczuk M, et al. Association of rs699 (M235T) polymorphism in the AGT gene with power but not endurance athlete status. The Journal of Strength & Conditioning Research. 2013;27(10):2898-903.
7. Kelley EF, Johnson BD, Snyder EM. Beta-2 adrenergic receptor genotype influences power output in healthy subjects. Journal of strength and conditioning research. 2017;31(8):2053.
8. Boulygina EA, Borisov OV, Valeeva EV, Semenova EA, Kostryukova ES, Kulemin NA, et al. Whole genome sequencing of elite athletes. Biology of Sport. 2020;37(3):295.
9. Corvol P, Jeunemaitre X. Molecular genetics of human hypertension: role of angiotensinogen. Endocrine reviews. 1997;18(5):662-77.
10. Gomez-Gallego F, Santiago C, González-Freire M, Yvert T, Muniesa CA, Serratosa L, et al. The C allele of the AGT Met235Thr polymorphism is associated with power sports performance. Applied Physiology, Nutrition, and Metabolism. 2009;34(6):1108-11.
11. Alves GB, Oliveira EM, Alves CR, Rached HR, Mota GF, Pereira AC, et al. Influence of angiotensinogen and angiotensin-converting enzyme polymorphisms on cardiac hypertrophy and improvement on maximal aerobic capacity caused by exercise training. European Journal of Preventive Cardiology. 2009; 16(4):92-487.
12. Wolfarth B, Rankinen T, Mühlbauer S, Scherr J, Boulay MR, Pérusse L, et al. Association between a β2-adrenergic receptor polymorphism and elite endurance performance. Metabolism. 2007;56(12):1649-51.
13. Sawczuk M, Maciejewska-Karlowska A, Cieszczyk P, Skotarczak B, Ficek K. Association of the ADRB2 Gly16Arg and Glu27Gln polymorphisms with athlete status. Journal of sports sciences. 2013;31(14):1535-44.